Azenta, Inc. (AZTA) has a MoatMap StockRank of 40/100 based on Quality (48/100), Value (50/100), and Momentum (29/100) factor scores. The current signal is HOLD. Life sciences sample management provider struggling with organic growth and failing to show the high-utilization pricing power of top-tier biologics CDMOs.
Azenta, Inc. provides life sciences solutions, including automated sample management systems, consumables, and genomics services to pharmaceutical, biotech, and academic researchers. A leader in its field, its integrated solutions, proprietary automation, and global infrastructure improve research efficiency and reliability, creating a competitive advantage. Azenta is a pure-play life sciences technology company, well-positioned for growth in genomics and sample preservation.
| Price | $22.72 |
| Market Cap | $1.0B |
| P/E (Forward) | 37.20 |
| Price/Book | 0.68 |
| Return on Equity | -6.8% |
| Return on Invested Capital | -1.2% |
| Debt/Equity | 3.58 |
| Gross Margin | 44.3% |
| Operating Margin | -10.6% |
| Revenue Growth | 1.0% |
| Free Cash Flow | $101M |
Azenta, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).